Share-based Payment Arrangement, Expense of BIO KEY INTERNATIONAL INC from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIO KEY INTERNATIONAL INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • BIO KEY INTERNATIONAL INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $31,660, a 52% decline year-over-year.
  • BIO KEY INTERNATIONAL INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $177,618, a 3.2% decline year-over-year.
  • BIO KEY INTERNATIONAL INC annual Share-based Payment Arrangement, Expense for 2024 was $243,250, a 8.5% decline from 2023.
  • BIO KEY INTERNATIONAL INC annual Share-based Payment Arrangement, Expense for 2023 was $265,732, a 31% decline from 2022.
  • BIO KEY INTERNATIONAL INC annual Share-based Payment Arrangement, Expense for 2022 was $387,907, a 23% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIO KEY INTERNATIONAL INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $177,618 $31,660 -$34,393 -52% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $212,011 $21,837 -$26,934 -55% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $238,945 $52,488 -$4,305 -7.6% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $243,250 $71,633 +$59,844 +508% 01 Oct 2024 31 Dec 2024 10-K 23 Apr 2025 2024 FY
Q3 2024 $183,406 $66,053 -$39,119 -37% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $222,525 $48,771 -$28,625 -37% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $251,150 $56,793 -$14,582 -20% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $265,732 $11,789 -$99,023 -89% 01 Oct 2023 31 Dec 2023 10-K 23 Apr 2025 2024 FY
Q3 2023 $364,755 $105,172 +$21,473 +26% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $343,282 $77,396 -$6,303 -7.5% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $349,585 $71,375 -$38,322 -35% 01 Jan 2023 31 Mar 2023 10-Q 14 Jun 2024 2024 Q1
Q4 2022 $387,907 $110,812 +$36,418 +49% 01 Oct 2022 31 Dec 2022 10-K 05 Jun 2024 2023 FY
Q3 2022 $351,489 $83,699 +$25,649 +44% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $325,840 $83,699 +$42,576 +104% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q1 2022 $283,264 $109,697 -$31,451 -22% 01 Jan 2022 31 Mar 2022 10-Q 09 Jun 2023 2023 Q1
Q4 2021 $314,715 $74,394 -$7,913 -9.6% 01 Oct 2021 31 Dec 2021 10-K 01 Jun 2023 2022 FY
Q3 2021 $322,628 $58,050 +$3,820 +7% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $318,808 $41,123 -$101,716 -71% 01 Apr 2021 30 Jun 2021 10-Q 17 Aug 2022 2022 Q2
Q1 2021 $420,524 $141,148 -$371,571 -72% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q4 2020 $792,095 $82,307 -$71,225 -46% 01 Oct 2020 31 Dec 2020 10-K 01 Apr 2022 2021 FY
Q3 2020 $863,320 $54,230 -$82,871 -60% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $946,191 $142,839 +$11,785 +9% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $934,406 $512,719 -$13,314 -2.5% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $947,720 $153,532 +$69,129 +82% 01 Oct 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $878,591 $137,101 -$59,245 -30% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $937,836 $131,054 -$18,488 -12% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $956,324 $526,033 -$23,900 -4.3% 01 Jan 2019 31 Mar 2019 10-Q 08 Jun 2020 2020 Q1
Q4 2018 $980,224 $84,403 -$85,368 -50% 01 Oct 2018 31 Dec 2018 10-K 14 May 2020 2019 FY
Q3 2018 $1,065,592 $196,346 -$32,364 -14% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $1,097,956 $149,542 -$263,652 -64% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $1,361,608 $549,933 +$388,844 +241% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $972,764 $169,771 +$22,911 +16% 01 Oct 2017 31 Dec 2017 10-K/A 05 Apr 2019 2018 FY
Q3 2017 $949,853 $228,710 +$172,026 +303% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $777,827 $413,194 +$363,259 +727% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $414,568 $161,089 -$13,274 -7.6% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $427,842 $146,860 +$64,042 +77% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $363,800 $56,684 +$20,634 +57% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $343,166 $49,935 -$10,093 -17% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $353,259 $174,363 +$12,144 +7.5% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $341,115 $82,818 +$45,842 +124% 01 Oct 2015 31 Dec 2015 10-K/A 04 Apr 2017 2016 FY
Q3 2015 $295,273 $36,050 -$2,014 -5.3% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $297,287 $60,028 +$13,583 +29% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $283,704 $162,219 +$76,446 +89% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $207,258 $36,976 +$17,606 +91% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 $189,652 $38,064 +$15,809 +71% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 $173,843 $46,445 +$18,875 +68% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $154,968 $85,773 +$73,326 +589% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 $81,642 $19,370 +$13,147 +211% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 $68,495 $22,255 +$15,310 +220% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $53,185 $27,570 +$11,637 +73% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $41,548 $12,447 -$8,294 -40% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $49,842 $6,223 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $6,945 -$5,993 -46% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 $15,933 +$6,742 +73% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 $20,741 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q3 2011 $12,938 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3
Q2 2011 $9,191 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2

BIO KEY INTERNATIONAL INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $243,250 -$22,482 -8.5% 01 Jan 2024 31 Dec 2024 10-K 23 Apr 2025 2024 FY
2023 $265,732 -$122,175 -31% 01 Jan 2023 31 Dec 2023 10-K 23 Apr 2025 2024 FY
2022 $387,907 +$73,192 +23% 01 Jan 2022 31 Dec 2022 10-K 05 Jun 2024 2023 FY
2021 $314,715 -$477,380 -60% 01 Jan 2021 31 Dec 2021 10-K 01 Jun 2023 2022 FY
2020 $792,095 -$155,625 -16% 01 Jan 2020 31 Dec 2020 10-K 01 Apr 2022 2021 FY
2019 $947,720 -$32,504 -3.3% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
2018 $980,224 +$7,460 +0.77% 01 Jan 2018 31 Dec 2018 10-K 14 May 2020 2019 FY
2017 $972,764 +$544,922 +127% 01 Jan 2017 31 Dec 2017 10-K/A 05 Apr 2019 2018 FY
2016 $427,842 +$86,727 +25% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $341,115 +$133,857 +65% 01 Jan 2015 31 Dec 2015 10-K/A 04 Apr 2017 2016 FY
2014 $207,258 +$125,616 +154% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $81,642 +$31,800 +64% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $49,842 -$7,338 -13% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 $57,180 01 Jan 2011 31 Dec 2011 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.